{"id":"W4293558161","doi":"10.1016/j.eururo.2022.08.005","title":"Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Olaparib; Interquartile range; Prostate cancer; Internal medicine; Response Evaluation Criteria in Solid Tumors; Pembrolizumab; Oncology; Adverse effect; Cohort; Tolerability; Urology; Progressive disease; Cancer; Disease; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003910029,0.000882622,0.001427422,0.0003409422,0.0006471938,0.001053748,0.0007726509,0.000856353,0.001616347],"category_scores_gemma":[0.002458838,0.0005001997,0.001643774,0.0006860008,0.0005628164,0.0008815675,0.0005187931,0.001880336,0.0004865749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001186646,"about_ca_system_score_gemma":0.001953231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003164798,"about_ca_topic_score_gemma":0.003691781,"domain_scores_codex":[0.9987007,0.0006138278,0.00009549646,0.0002249817,0.0001971272,0.0001677464],"domain_scores_gemma":[0.9979401,0.0002704986,0.0006266172,0.0002395767,0.0001522809,0.000770867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.696654,0.02914922,0.1791413,0.0008642982,0.006138025,0.0004591641,0.0005236198,0.001263517,0.01494905,0.0001909435,0.005149692,0.06551715],"study_design_scores_gemma":[0.286736,0.2453318,0.4477011,0.0001894502,0.006303577,0.0008728169,0.0003626927,0.001735565,0.00298877,0.0002272297,0.007430273,0.0001206624],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939487,0.003117946,0.0002511872,0.0002238063,0.00005891725,0.0004602575,0.001405579,0.00002334151,0.0005102528],"genre_scores_gemma":[0.9937962,0.001311295,0.0004596296,0.0004726191,0.0002092245,0.0003458659,0.002906351,0.00001081289,0.0004880299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003910029,"threshold_uncertainty_score":0.02067846,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02590916212518864,"score_gpt":0.3095457383498139,"score_spread":0.2836365762246253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}